Christina Espineta
Medical · Naples, FLNPI 1558559013
Payments from drug & device makers
Across 162 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$973
- AbbVie$390
- Boehringer Ingelheim$370
- AstraZeneca$311
- Galderma Laboratories, L.p.$219
- Amgen$199
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,722100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $973 |
| AbbVie | 21 | $390 |
| Boehringer Ingelheim | 21 | $370 |
| AstraZeneca | 14 | $311 |
| Galderma Laboratories, L.p. | 4 | $219 |
| Amgen | 7 | $199 |
| Bayer | 4 | $185 |
| Lilly USA, LLC | 11 | $184 |
| Revance Therapeutics, Inc. | 2 | $157 |
| Esperion Therapeutics, Inc. | 6 | $114 |
| Merck | 5 | $107 |
| GSK | 6 | $99 |
| Abbott | 3 | $76 |
| Astellas Pharma US Inc | 3 | $51 |
| Radius Health, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $40 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Pfizer | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,722 in reported general payments places this provider in the 80th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 13 | $130 |
| Rosuvastatin Calcium | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Other medical in Naples
- Shanna MirantiNaples$415K
- Yekaterina GrigolNaples$18K
- Gary RubinRockledge$2.1M
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.